Jane A. Gross - 17 May 2023 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
LIFE
Transactions as of
17 May 2023
Transactions value $
$0
Form type
4
Filing time
19 May 2023, 16:29:03 UTC
Previous filing
28 Apr 2023
Next filing
23 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Stock Option (right to buy) Award $0 +12,000 $0 12,000 17 May 2023 Common Stock 12,000 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.